Skip to main content
Caplight Logo









TruDiary

TruDiary

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://trudiary.com

Last Round

Accelerator

Jan 10, 2023

Total Funding Raised

$174,000

Company Overview

TruDiary operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. Its latest recorded funding round was an Accelerator round in January 2023.

TruDiary is a health technology company that provides a maternal and reproductive health platform offering curated content and social determinants of health services to improve pregnancy outcomes.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Home & Lifestyle

Business Model

B2B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

TruDiary Comparables

Compare TruDiary with similar companies based on industry and business-model similarity.

TruDiary comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Wolomi
82%
Mae Health Inc.
78%
Labcorp
75%
Book a demo to see all comparables

For institutional investors. Book with your work email.

TruDiary Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJan 10, 2023
AcceleratorDec 12, 2021
GrantOct 19, 2020
AcceleratorOct 1, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

TruDiary Investors

Notable investors and investment history

TruDiary investors
InvestorRounds
Nex CubedAccelerator
gener8torAccelerator
gBETA MedtechAccelerator
Camelback VenturesAccelerator
GoogleGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 10, 2023

    $40K round led by Camelback Ventures

  • Dec 12, 2021

    $34K round led by gBETA Medtech

Book a demo to see all signals

For institutional investors. Book with your work email.

TruDiary Filings

Explore SEC and related filing metadata, where available.

TruDiary filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about TruDiary's valuation, stock price, and market status.

Is TruDiary a public or private company?

TruDiary is a private company.

What is the current stock price of TruDiary?

TruDiary is a private company, so its shares have no public market price. Caplight tracks TruDiary's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is TruDiary worth (valuation)?

Valuation information for TruDiary is not publicly available.

Can I buy TruDiary stock?

TruDiary shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was TruDiary's last funding round?

TruDiary's most recent funding round was Accelerator on January 10, 2023.

Who are the main investors in TruDiary?

Key investors in TruDiary include Nex Cubed, gBETA Medtech, Camelback Ventures.

Will TruDiary IPO soon?

No public IPO plans have been announced for TruDiary.

How can I track TruDiary secondary market activity?

Caplight tracks bids, offers, and trades in TruDiary's shares on secondary markets.

Firmographic Details

HeadquartersAtlanta, Georgia
Year FoundedN/A
Last FundingJan 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?